Cargando…
Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways
High-Risk neuroblastoma (NB) survival rate is still <50%, despite treatments being more and more aggressive. The biggest hurdle liable to cancer therapy failure is the drug resistance by tumor cells that is likely due to the intra-tumor heterogeneity (ITH). To investigate the link between ITH and...
Autores principales: | Avitabile, Marianna, Bonfiglio, Ferdinando, Aievola, Vincenzo, Cantalupo, Sueva, Maiorino, Teresa, Lasorsa, Vito Alessandro, Domenicotti, Cinzia, Marengo, Barbara, Zbyněk, Heger, Vojtěch, Adam, Iolascon, Achille, Capasso, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418686/ https://www.ncbi.nlm.nih.gov/pubmed/36051886 http://dx.doi.org/10.1016/j.csbj.2022.08.031 |
Ejemplares similares
-
CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
por: Formicola, Daniela, et al.
Publicado: (2022) -
Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2020) -
Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma
por: Bonfiglio, Ferdinando, et al.
Publicado: (2022) -
FGFR1 is a potential therapeutic target in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2022) -
Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
por: Avitabile, Marianna, et al.
Publicado: (2020)